Yu G, Zhang W, Basyal M, Nishida Y, et al. The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinases. Leuk Lymphoma 2024 Jun 13:1-16. doi: 10.1080/10428194.2024.2364839.
PMID: 38871487